(Q36298874)

13 August 2017

1 reference

title

The search for a tuberculosis vaccine: an elusive quest? (English)

1 reference

13 August 2017

1 reference

2

Sake J de Vlas

1 reference

13 August 2017

4

Tom H M Ottenhoff

1 reference

13 August 2017

5

Martien Borgdorff

1 reference

13 August 2017

Nico J D Nagelkerke

1

1 reference

PubMed ID

16253559

13 August 2017

Yodi Mahendradhata

series ordinal

3

1 reference

13 August 2017

25 October 2005

1 reference

13 August 2017

1 reference

13 August 2017

86

1 reference

13 August 2017

1

1 reference

13 August 2017

41-46

1 reference

The TB epidemic from 1992 to 2002.

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

M. tuberculosis: immunology and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Immunology of tuberculosis and implications in vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Tuberculosis: a problem with persistence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Genetic susceptibility to tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Immunity, immunopathology and vaccines against HIV?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Development of new vaccines and diagnostic reagents against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

7 January 2021

Tuberculosis vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

New vaccines against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Tuberculosis vaccine development: research, regulatory and clinical strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Re: "The age of selection of mortality from tuberculosis in successive decades"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Immune evasion by Mycobacterium tuberculosis: living with the enemy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

The intrinsic transmission dynamics of tuberculosis epidemics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Is the development of a new tuberculosis vaccine possible?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Hijacking and exploitation of IL-10 by intracellular pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Regulation of macrophage activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Can eradication of helminthic infections change the face of AIDS and tuberculosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

High prevalence of hepatitis B virus infection among tuberculosis patients with and without HIV in Rio de Janeiro, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Seroepidemiological associations between tuberculosis, malaria, hepatitis B, and AIDS in West Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

Tuberculosis and sexually transmitted infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2005.06.001

10.1016/J.TUBE.2005.06.001

7 January 2021

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16253559